Showing results (121-130 of 154) with videos related to
Sort By:
Pageof 16
The Lancet. Neurology|September 20, 2024
Differential diagnosis of suspected multiple sclerosis: considerations in people from minority ethnic and racial backgrounds in North America, northern Europe, and AustralasiaLilyana Amezcua, Dalia Rotstein, Afsaneh Shirani, et al.Journal of Medical Imaging and Radiation Oncology|December 6, 2012
Adherence to MRI protocol consensus guidelines in multiple sclerosis: an Australian multi-centre studyMichael Curley, Lawrence Josey, Robyn Lucas, et al.Cancers|July 24, 2021
The PATHFINDER Study: Assessment of the Implementation of an Investigational Multi-Cancer Early Detection Test into Clinical PracticeLincoln D Nadauld, Charles H McDonnell, Tomasz M Beer, et al.Life Science Alliance|June 11, 2020
Multiple sclerosis risk variants regulate gene expression in innate and adaptive immune cellsMelissa M Gresle, Margaret A Jordan, Jim Stankovich, et al.American Journal of Human Genetics|April 2, 2002
Genetic dissection of the human leukocyte antigen region by use of haplotypes of Tasmanians with multiple sclerosisJustin P Rubio, Melanie Bahlo, Helmut Butzkueven, et al.Plos One|November 30, 2022
Coral restoration and adaptation in Australia: The first five yearsIan M McLeod, Margaux Y Hein, Russ Babcock, et al.American Journal of Preventive Medicine|May 27, 2019
An RCT of Dating Matters: Effects on Teen Dating Violence and Relationship BehaviorsPhyllis Holditch Niolon, Alana M Vivolo-Kantor, Allison J Tracy, et al.European Journal of Neurology|March 16, 2021
Risk of requiring a wheelchair in primary progressive multiple sclerosis: Data from the ORATORIO trial and the MSBase registryHelmut Butzkueven, Tim Spelman, Dana Horakova, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|October 6, 2011
Uptake, efficacy, and systemic distribution of naked, inhaled short interfering RNA (siRNA) and locked nucleic acid (LNA) antisenseSterghios A Moschos, Manfred Frick, Bruce Taylor, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|October 8, 2021
Prediction of multiple sclerosis outcomes when switching to ocrelizumabMichael Zhong, Anneke van der Walt, Jim Stankovich, et al.Pageof 16